ImpediMed Limited (ASX:IPD)
0.0170
+0.0010 (6.25%)
At close: Mar 9, 2026
ImpediMed Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -24.37 | -23.24 | -19.79 | -20.52 | -19.87 | -20.71 | Upgrade
|
| Depreciation & Amortization | 0.47 | 0.57 | 0.58 | 0.55 | 1.24 | 0.35 | Upgrade
|
| Other Amortization | 3.99 | 3.99 | 1.67 | 1.92 | 1.81 | 1.3 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.05 | Upgrade
|
| Stock-Based Compensation | 1.6 | 1.6 | -0.68 | 0.75 | 3 | 3.04 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.05 | 0.05 | -0.23 | -0.65 | -0.45 | -0.3 | Upgrade
|
| Other Operating Activities | 0.98 | 0.49 | -0.02 | 0.33 | 0.4 | 0.64 | Upgrade
|
| Change in Accounts Receivable | 1.08 | 1.08 | 1.18 | 0.18 | 0.04 | -0.08 | Upgrade
|
| Change in Inventory | -0.1 | -0.1 | 0.05 | 0.12 | -0.55 | 0.49 | Upgrade
|
| Change in Accounts Payable | -0.06 | -0.06 | 0.12 | -0.89 | 1.53 | -0.28 | Upgrade
|
| Change in Other Net Operating Assets | 0.97 | 0.97 | -0.67 | 0.17 | -2.79 | 2.26 | Upgrade
|
| Operating Cash Flow | -15.39 | -14.65 | -17.79 | -18.05 | -15.66 | -13.26 | Upgrade
|
| Capital Expenditures | -0.06 | -0.06 | -0.08 | -0.39 | -0.06 | -0.07 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.81 | -0.93 | -3.02 | -5.65 | -5.16 | -2.39 | Upgrade
|
| Other Investing Activities | -0.03 | - | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.91 | -0.99 | -3.11 | -6.04 | -5.22 | -2.46 | Upgrade
|
| Long-Term Debt Issued | - | 15.97 | - | - | - | 0.17 | Upgrade
|
| Long-Term Debt Repaid | - | -0.42 | -0.48 | -0.43 | -0.37 | -0.41 | Upgrade
|
| Net Debt Issued (Repaid) | 23.27 | 15.55 | -0.48 | -0.43 | -0.37 | -0.24 | Upgrade
|
| Issuance of Common Stock | - | - | 0.06 | 30.02 | 42.5 | 16.84 | Upgrade
|
| Other Financing Activities | -3.35 | -1.9 | -0.06 | -1.67 | -2.21 | -0.13 | Upgrade
|
| Financing Cash Flow | 19.92 | 13.64 | -0.48 | 27.93 | 39.92 | 16.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.47 | -0.46 | 0.3 | 1.14 | 2.02 | -0.73 | Upgrade
|
| Net Cash Flow | 1.15 | -2.45 | -21.08 | 4.98 | 21.05 | 0.02 | Upgrade
|
| Free Cash Flow | -15.45 | -14.71 | -17.87 | -18.44 | -15.72 | -13.32 | Upgrade
|
| Free Cash Flow Margin | -108.54% | -115.57% | -173.18% | -162.56% | -148.82% | -158.45% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Cash Interest Paid | 2.03 | 0.58 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -10.88 | -9.36 | -15.83 | -18.95 | -13.31 | -9.13 | Upgrade
|
| Unlevered Free Cash Flow | -8.98 | -8.63 | -15.77 | -18.93 | -13.3 | -9.1 | Upgrade
|
| Change in Working Capital | 1.89 | 1.89 | 0.68 | -0.43 | -1.78 | 2.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.